Teva: Romania is a priority within the group - Azi

All news

Teva, leader of the global generics market, targets a 60% turnover growth rate this year, to 16m euros, and a 25% increase in 2009, as part of the aggressive strategy the Israeli group is preparing for Romania.

"For Teva, Romania has become a priority, both in terms of the size and trend of the Romanian pharmaceutical market, and owing to the opportunities arising from its EU integration. This year, we"ve gone through a period of internal reorganisation, both domestically and internationally,...

Read the whole story in: Ziarul Financiar